Search clinical trials for: Everolimus and Pasireotide
Total 272948 results
-
AnewPharmaUnknownRenal Cell Cancer MetastaticChina
-
Foundation of Cardiovascular Research and Education...CompletedCoronary Artery Disease | Angina Pectoris | Unstable Angina Pectoris | Coronary Stenosis | Coronary RestenosisNetherlands
-
Ajou University School of MedicineUnknownCoronary Artery DiseaseKorea, Republic of
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaCompletedIn-stent RestenosisKorea, Republic of
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaCompletedCoronary Artery DiseaseKorea, Republic of
-
Fox Chase Cancer CenterNovartis PharmaceuticalsTerminatedSporadic Angiomyolipomas (AMLs)United States
-
Yale UniversityNovartis PharmaceuticalsTerminatedBreast CancerUnited States
-
Novartis PharmaceuticalsCompletedKidney TransplantKorea, Republic of
-
Gustave Roussy, Cancer Campus, Grand ParisTerminated
-
Herlev HospitalOdense University Hospital; Aalborg University HospitalCompletedMetastatic Colorectal CancerDenmark
-
Novartis PharmaceuticalsCompleted
-
Eisai Inc.Merck Sharp & Dohme LLCActive, not recruitingRenal Cell CarcinomaSpain, Canada, Portugal, Korea, Republic of, Taiwan, United States, Netherlands, United Kingdom, Czechia, Italy, Finland, Greece, Romania, Australia, Poland, Russian Federation
-
University Hospital, Strasbourg, FranceActive, not recruitingBK Virus Nephropathy After Kidney TransplantationFrance
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingThyroid CancerUnited States
-
Novartis PharmaceuticalsCompletedCarcinoma | Neuroendocrine | Advanced and Metastatic Silent Neuro-Endocrine Tumors | Non Functioning Neuroendocrine Tumors (NETs) | Non Syndromic Neuroendocrine Tumors | Carcinoids | Non FunctioningSweden, Italy, Germany, United Kingdom, Spain, France, Netherlands, Poland
-
Novartis PharmaceuticalsCompletedAdvanced Gastric CancerJapan
-
St. Jude Children's Research HospitalNovartisCompletedSarcoma, Soft Tissue | Brain Tumors | Rhabdomyosarcoma | TumorsUnited States
-
Organisation for Oncology and Translational ResearchUnknown
-
Gustave Roussy, Cancer Campus, Grand ParisNovartisUnknownNon-small Cell Lung Cancer | Locally Advanced DiseaseFrance
-
National Cancer Center, KoreaTerminatedMetastatic Breast CancerKorea, Republic of
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedCarcinoma of Unknown Primary OriginUnited States
-
Lepu Medical Technology (Beijing) Co., Ltd.Unknown
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Heinrich-Heine University, DuesseldorfTerminated
-
Maasstad HospitalCompletedAcute Coronary Syndrome | Stable Angina | Unstable AnginaNetherlands
-
GERCOR - Multidisciplinary Oncology Cooperative...Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Herbert Hurwitz, MDNovartis; Genentech, Inc.; AmgenCompleted
-
Sinai Hospital of BaltimoreUnknownOvarian Cancer | Endometrial CancerUnited States
-
M.D. Anderson Cancer CenterTerminatedLocally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
Hospices Civils de LyonWithdrawnFacial AngiofibromasFrance
-
Novartis PharmaceuticalsCompletedLymphangioleiomyomatosisFrance, United States, Italy
-
NYU Langone HealthCompletedNeurofibromatosis Type 2 | Meningiomas | Vestibular SchwannomasUnited States
-
Novartis PharmaceuticalsCompletedRenal Cell CarcinomaSouth Africa, Egypt, Saudi Arabia, Russian Federation, Lebanon, Thailand, Jordan, India, Tunisia, Algeria
-
Mario Negri Institute for Pharmacological ResearchTerminated
-
iOMEDICO AGNovartisCompletedMetastatic Renal Cell Carcinoma | Failure of Exactly One Prior VEGF-targeted TherapyGermany
-
Novartis PharmaceuticalsWithdrawnKidney TransplantationSwitzerland
-
Istituti Ospitalieri di CremonaUnknownSafety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast CancersTriple Negative Breast CancerItaly
-
Seoul National University HospitalCompleted
-
Hannover Medical SchoolNovartisCompletedTesticular Cancer | Germ Cell CancerGermany
-
Queen Mary University of LondonNovartisCompletedMetastatic Clear Cell Renal CancerUnited Kingdom
-
Austin HealthUnknown
-
Sheba Medical CenterUnknown
-
Ural State Medical UniversityUral Institute of Cardiology; Ural Federal University; De Haar Research FoundationTerminatedCoronary Artery Disease | AtherosclerosisNetherlands, Russian Federation
-
Fudan UniversityRecruitingKidney Cancer | Renal Cell Carcinoma | Renal Clear Cell CarcinomaChina
-
Richard Stone, MDMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalActive, not recruitingRAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDSAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Arvinas Estrogen Receptor, Inc.PfizerActive, not recruitingBreast CancerUnited States, Spain
-
Southern Europe New Drug OrganizationBayer; NovartisSuspendedAdvanced Solid TumorsItaly
-
University of ZurichNovartis; Swiss National Science FoundationCompletedAcute Coronary SyndromesSwitzerland, Germany
-
Novartis PharmaceuticalsCompletedHepatic InsufficiencyGermany, Russian Federation, Singapore